Search for stocks /

Sheela Foam Q1 FY26: 47% Core EBITDA Jump, but EPS Sleeps Like a Baby


At a Glance

Sheela Foam (Sleepwell, Kurlon, Furlenco) just pulled off a foam party in its Q1 FY26 results—revenues rose 5% YoY to ₹821 crore, and core EBITDA inflated 47% (like a well-pumped air mattress). But before you start dreaming, net profit collapsed 64% to ₹7 crore and EPS is snoring at ₹0.68. The company boasts a massive 30% market share in India and 40% in Australia’s PU foam market, yet the stock trades at a P/E of 133, making it look more like a luxury mattress—comfortable only for those who can afford the risk.


Introduction

Sheela Foam, the maker of Sleepwell, continues to dominate your bedroom but struggles to dominate investors’ hearts. While the brand screams premium comfort, its financials scream “wake up!” Sales growth barely limped at 5% this quarter, and margins were rescued mainly by cost management rather than any top-line fireworks. Promoter holding has dropped by over 7% in three years, raising eyebrows as fast as its borrowing levels. The cherry? A P/E of 133—because apparently, investors love paying luxury prices for a company earning economy-class profits.


Business Model (WTF Do They Even Do?)

Think of Sheela Foam as the foam mafia—if it’s soft, bouncy, and in your living room, chances are they made it. They manufacture PU foam and mattresses under Sleepwell (India’s darling), Kurlon (the old school player), and even own Aussie market share (40%!). Their product spread covers mattresses, pillows, furniture cushions, and even industrial foams. The strategy is simple: dominate the premium market, keep the branding strong, and expand via acquisitions (remember Furlenco?). Problem: while the beds are comfy, the balance sheet is not. Growth has been sluggish, with sales CAGR at 6% over three years. This is a classic case of brand strength battling weak financial stamina.


Financials Overview

For Q1 FY26:

  • Revenue: ₹821 crore (+5% YoY)
  • EBITDA: ₹75 crore (+47% YoY)
  • Net Profit: ₹7 crore (-64% YoY)
  • EPS: ₹0.68

The jump in EBITDA is due to cost cuts and better mix, not demand explosion. Net profit tanked thanks to high depreciation (₹46 crore) and interest (₹29 crore). Annual figures show FY25 PAT at ₹97 crore, down from ₹184 crore in FY24. Growth? Flat as

Continue reading with a premium membership.
Become a member
error: Content is protected !!